Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 4/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL5936849 | 0.92 | ALDH1A1 (0.41) | RIPK1CA4POLBLTA4HPPARG | |
| Oxirane SCHEMBL28516386 | 0.90 | RIPK1 (0.36) | RIPK1CA4SLC6A2TAAR1POLB | |
| Phosphoric Acid SCHEMBL23610951 | 0.89 | ALDH1A1 (0.44) | POLBTSHRPPARGPPARAALDH1A1 | |
| SCHEMBL3517534 | 0.88 | CYP3A4 (0.38) | TSHRPPARGPPARA | |
| SCHEMBL17832183 | 0.84 | CA4 (0.37) | RIPK1CA4SLC6A2TAAR1LTA4H | |
| SCHEMBL15202532 | 0.83 | SLC6A2 (0.39) | RIPK1CA4SLC6A2TAAR1LTA4H | |
| SCHEMBL17772105 | 0.83 | PPARG (0.37) | RIPK1CA4SLC6A2TAAR1LTA4H | |
| SCHEMBL13639223 | 0.82 | CYP3A4 (0.35) | RIPK1SLC6A2TSHRPPARGPPARA | |
| SCHEMBL28141859 | 0.81 | CA4 (0.42) | RIPK1CA4SLC6A2TAAR1LTA4H | |
| SCHEMBL183720 | 0.79 | LTA4H (0.40) | RIPK1CA4SLC6A2TAAR1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4352252-B1 | METHODS FOR SPATIAL ANALYSIS USING TARGETED PROBE SILENCING | 10X GENOMICS INC (US) | 2026-01-28 | — | — | EP | claimed |
| US-20260016466-A1 | TEST PIECE FOR MEASURING ALBUMIN AND METHOD FOR MEASURING ALBUMIN | FUJIFILM CORPORATION (JP) | 2026-01-15 | — | — | US | claimed |
| US-12517286-B2 | Method of producing single layer omnidirectional broadband antireflective and super hydrophilic (antifogging) coatings for solar and other applications | INTERNATIONAL ADVANCED RESEARCH CENTRE FOR POWDER METALLURGY AND NEW MATERIALS (ARCI) (IN) | 2026-01-06 | — | — | US | claimed |
| WO-2025238653-A1 | MULTI-LAYER COATING FOR PHOTOVOLTAIC GLASS | BOROSIL RENEWABLES LIMITED (IN) | 2025-11-20 | — | — | WO | claimed |
| WO-2025226754-A1 | METHOD FOR PREDICTING OSMOLALITY OF PROTEIN SOLUTIONS | AMGEN INC. (US) | 2025-10-30 | — | — | WO | claimed |
| EP-3494396-B1 | CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF | PIERCE BIOTECHNOLOGY INC (US) | 2025-06-11 | — | — | EP | claimed |
| US-12312381-B2 | Capture purification processes for proteins expressed in a non-mammalian system | AMGEN INC. (US) | 2025-05-27 | — | — | US | claimed |
| EP-4320271-B1 | METHODS FOR INCREASING RESOLUTION OF SPATIAL ANALYSIS | 10X GENOMICS INC (US) | 2025-03-19 | — | — | EP | claimed |
| CN-119592455-A | Preparation method of outer membrane vesicle protein of group B meningococcus | 成都欧林生物科技股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119506014-A | Detergent for actinide nuclide pollution and preparation method thereof | 中国辐射防护研究院 | 2025-02-25 | — | — | CN | claimed |
| CN-103571825-A | Composition for biological sample treatment and nucleic acid amplification method using the same | IND TECH RES INST | 2014-02-12 | — | — | CN | claimed |
| CN-103571824-A | Compositions and methods for isolating nucleic acids | IND TECH RES INST | 2014-02-12 | — | — | CN | claimed |
| US-20130334063-A1 | Method of Detecting Analyte | GORDON & ROSENBLATT, LLC (US) | 2013-12-19 | — | — | US | claimed |
| EP-2621599-A1 | IMPROVED ELECTRON TRANSPORT LAYER | The Technical University of Denmark (DK) | 2013-08-07 | — | — | EP | claimed |
| US-20130053254-A1 | PROCESS FOR PARALLEL ISOLATION AND/OR PURIFICATION OF RNA AND DNA | QIAGEN GMBH (DE) | 2013-02-28 | — | — | US | claimed |
| EP-2539449-A1 | PROCESS FOR PARALLEL ISOLATION AND/OR PURIFICATION OF RNA AND DNA | Qiagen GmbH (DE) | 2013-01-02 | — | — | EP | claimed |
| WO-2012041847-A1 | IMPROVED ELECTRON TRANSPORT LAYER | THE TECHNICAL UNIVERSITY OF DENMARK (DK) | 2012-04-05 | — | — | WO | claimed |
| WO-2012041853-A2 | IMPROVED ADHESION OF METAL OXIDE LAYER | THE TECHNICAL UNIVERSITY OF DENMARK (DK) | 2012-04-05 | — | — | WO | claimed |
| WO-2007071377-A1 | CONVERSION REAGENT AND METHOD AND KIT FOR DETERMINING HAEMOGLOBIN | MEDISYNTHANA DIAGNOSTICS GMBH & CO. KG (DE) | 2007-06-28 | — | — | WO | claimed |
| US-6207098-B1 | Method for producing porous inorganic materials | MERCK PATENT GMBH (DE) | 2001-03-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260016466-A1 | TEST PIECE FOR MEASURING ALBUMIN AND METHOD FOR MEASURING ALBUMIN | ALB, S100P, MB | RIPK1 1984/4885CA4 1211/4885SLC6A2 3727/4885 |
| US-20130053254-A1 | PROCESS FOR PARALLEL ISOLATION AND/OR PURIFICATION OF RNA AND DNA | POLRMT, POLB, POLR2H | RIPK1 3069/4885CA4 2664/4885SLC6A2 3188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.